HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 747: | Line 747: | ||
| | | | ||
| | | | ||
| | |Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 | ||
|Tracy Tucker, PhD, FCCMG | |Tracy Tucker, PhD, FCCMG | ||
| | | | ||
| Line 763: | Line 763: | ||
| | | | ||
| | | | ||
| | |Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged | ||
|Tracy Tucker, PhD, FCCMG | |Tracy Tucker, PhD, FCCMG | ||
| | | | ||
| Line 779: | Line 779: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|[[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid|Mixed-phenotype acute leukaemia, B/myeloid]] | |[[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid|Mixed-phenotype acute leukaemia, B/myeloid]] | ||
| Line 795: | Line 795: | ||
| | | | ||
| | | | ||
| | |Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified | ||
|Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD | |Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD | ||
| | | | ||
| Line 811: | Line 811: | ||
| | | | ||
| | | | ||
| | |Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified | ||
|Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine | |Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine | ||
| | | | ||
| Line 827: | Line 827: | ||
| | | | ||
| | | | ||
| | |Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types | ||
|Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | |Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | ||
| | | | ||
| Line 843: | Line 843: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|[[HAEM5:Acute undifferentiated leukaemia|Acute undifferentiated leukaemia]] | |[[HAEM5:Acute undifferentiated leukaemia|Acute undifferentiated leukaemia]] | ||
| Line 859: | Line 859: | ||
| | | | ||
| | | | ||
| | |Acute Undifferentiated Leukemia | ||
|Amelia Nakanishi, MD and Shashi Shetty, PhD | |Amelia Nakanishi, MD and Shashi Shetty, PhD | ||
| | | | ||